Correction to: Immunosuppression Drug Therapy in Lung Transplantation for Cystic Fibrosis.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 207, doi. 10.1007/s40272-018-0285-1
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2018 AND VI 20 AND IP 2
Results: 11
1
2
The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 153, doi. 10.1007/s40272-018-0282-4
- By:
- Publication type:
- Article
3
Method Development for Clinical Comprehensive Evaluation of Pediatric Drugs Based on Multi-Criteria Decision Analysis: Application to Inhaled Corticosteroids for Children with Asthma.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 195, doi. 10.1007/s40272-017-0278-5
- By:
- Publication type:
- Article
4
Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 173, doi. 10.1007/s40272-017-0277-6
- By:
- Publication type:
- Article
5
Pediatric Asthma Management in China: Current and Future Challenges.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 105, doi. 10.1007/s40272-017-0276-7
- By:
- Publication type:
- Article
6
Correction to: Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 205, doi. 10.1007/s40272-017-0275-8
- By:
- Publication type:
- Article
7
Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 121, doi. 10.1007/s40272-017-0274-9
- By:
- Publication type:
- Article
8
Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 135, doi. 10.1007/s40272-017-0273-x
- By:
- Publication type:
- Article
9
Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 181, doi. 10.1007/s40272-017-0270-0
- By:
- Publication type:
- Article
10
Agents in Development for Childhood Acute Lymphoblastic Leukemia.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 111, doi. 10.1007/s40272-017-0268-7
- By:
- Publication type:
- Article
11
Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting.
- Published in:
- Pediatric Drugs, 2018, v. 20, n. 2, p. 165, doi. 10.1007/s40272-017-0267-8
- By:
- Publication type:
- Article